HOME - LATEST NEWS - Corporate - Lumosa Therapeutics is pleased to introduce our new CBO, Mr. Christopher Aleong

LATEST NEWS

Corporate

Corporate

2022.07.11

Lumosa Therapeutics is pleased to introduce our new CBO, Mr. Christopher Aleong

Chris has over 25 years of strategic cross-functional and cross-divisional experience in mature and emerging markets involving both regional and multi-country roles in the pharmaceutical and biotechnology industries. He is responsible for leading the BD team, sharing his vast knowledge in negotiation, deal-making, corporate strategy, and driving Lumosa's global presence and business acceleration as the Company expands into new territories and markets.